Patent · US Active

Modified ghrelin peptides

US9938332B2 · kind B2 · utility

0Cited by
4References
57Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 12, 2012
Grant dateApr 10, 2018
Priority date
Expiry dateJun 12, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K48/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a peptide-type compound which induces secretion of growth hormone and which has the activity of increasing the intracellular calcium ion concentration, wherein at least one amino acid is replaced by a modified amino acid and/or a non-amino acid compound, or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.